Healthcare and Life Sciences Disputes

A cross-border team renowned for its full-service healthcare & life sciences dispute resolution practice.

We’re recognised as a market leader for healthcare & life sciences. Our international team advises the world’s leading and most innovative pharma, biotech, medical device and healthcare companies.
We understand the challenges and the complexities of the sector from regulation to disputes. We provide relevant strategic advice and assistance tailored to each and every situation.
Healthcare & life sciences disputes by their nature are varied. For that reason, we’re more than a team of litigation lawyers - we’re scientists. Many of us have bioscience and pharma law qualifications, we’re analysts, we’re consultants with an in-dept knowledge and experience of your industry. And we’re law shapers.
We share your concerns, we care for your interest and we adapt to protect them. We’ll always put you first, using innovative and creative approaches to get the job done.

Our core services include:

  • Administrative, contentious regulatory and public law matters
  • Alternative dispute resolution
  • Civil litigation and arbitration (including in relation to injunctive and other interim relief),
  • Clinical trial agreements
  • Contractual disputes arising from licensing, co-promotion, manufacturing, distribution and supply agreements
  • Crime, fraud and investigatory work.
  • Judicial review and risk management.
  • Jurisdiction disputes arising from cross-border agreements
  • Litigation and arbitration
  • M&A litigation
  • Negotiation
  • Product liability claims
  • Regulatory compliance
  • Termination of joint venture agreements

Our experience

3M UK Holdings Limited

Advising 3M UK in its defence of a multi-million dollar Commercial Court claim brought by Porton Capital Technology Funds and others (and their subsequent appeal to the Court of Appeal) This was in relation to allegations of breach of contract arising out of the cessation of the commercialisation of a product developed for the clinical detection of MRSA.

Director of Pharma Consultancy

Advising the director of a UK-based pharmaceutical company, in his defence in the High Court and on appeal to the Court of Appeal, against claims of fraudulent and negligent misrepresentation and misstatement. This was in relation to an investment made in the company during its attempted commercialisation in the EU of a protein reverse-engineered from HIV and used for multiple therapeutic applications including treatment of ulcerative diseases of the gut.

Dutch biomedical company

Acting for the management of a Dutch biomedical company in inquiry proceedings before the specialised Enterprise Division of the Amsterdam Court of Appeal concerning issues of alleged corporate mismanagement in a hostile take-over context.